Funding for this research was provided by:
region occitanie/pyrénées-méditerranée (1901175)
european regional development fund (MP0022856)
Received: 30 July 2021
Accepted: 16 November 2021
First Online: 7 January 2022
: Eligible subjects provided written informed consent prior to inclusion. The MAPT Study Group was authorized by the French Health Authority and approved by the Advisory Committee for the Protection of Persons participating in Biomedical Research of Toulouse.
: Not applicable.
: The authors declare that they have no competing interests.